Premium
Six‐month oral clarithromycin regimen is safe and active in extranodal marginal zone B‐cell lymphomas: final results of a single‐centre phase II trial
Author(s) -
Govi Silvia,
Dognini Giuseppina P.,
Licata Giada,
Crocchiolo Roberto,
Resti Antonio Giordano,
Ponzoni Maurilio,
Ferreri Andrés J. M.
Publication year - 2010
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2010.08179.x
Subject(s) - clarithromycin , medicine , tolerability , pharmacology , oncology , clinical trial , regimen , immunology , helicobacter pylori , adverse effect